EVVIVAX
EVVIVAX is a biotechnology company that pursues the discovery and development of innovative therapeutic veterinary cancer vaccines based on viral vectors and DNA platform technologies. The company engineers the antigens and use combinations of different genetic immunization modalities (heterologous prime/boost) as a powerful approach to induce superior immune responses and achieve greater clinical efficacy. they also offer services such as electrochemotherapy, in vivo electroporation, genetic vaccine, electro-gene-transfer, and vet-eporatorTM. Its headquarters is located in Rome, Italy and was founded in 2016 by Luigi Aurisicchio.
EVVIVAX
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Veterinary Wellness
Founded:
2016-06-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Euro PHP PHP 7 COVID-19 CPanel SSL
Similar Organizations
Asclepia
ASCLEPIA is a Medicinal Chemistry oriented Research & Services by designing innovative, therapeutically relevant, druglike compounds.
Exeter Antioxidant Therapeutics Ltd.
Exeter Antioxidant Therapeutics Ltd. is a young, dynamic company established to further the development of therapeutic catalysts.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Pharmacure Health Care International AB
Pharmacure focuses on the development of new drug to improve the therapeutic the enhancing nasal comfort of our patients.
Swords Labs
Bristol-Myers Squibb is a biopharma company that works to discover, and deliver innovative medicines that help patients fight disease.
Founder
More informations about "EVVIVAX"
Evvivax - LinkedIn
EVVIVAX is a Biotech Company created in June 2016 as a spin off from Takis, a Biotech created by a group of scientists previously part of Merck Research Laboratories (MRL).See details»
Tel-eVax: a genetic vaccine targeting telomerase for treatment of ...
The electroporation was carried out with Vet-ePorator™, a device manufactured by IGEA (Carpi, Modena, Italy) for Evvivax and based on Cliniporator ... Jemal A, Flowers CR. 2016 US …See details»
Applied DNA Subsidiary LineaRx Enters New Partnership
Sep 20, 2018 The partnership will allow the companies to focus on developing anti-cancer vaccine candidates from Takis and Evvivax’s pipeline using LineaRx’s linear DNA technology.See details»
The Long Road Toward COVID-19 Herd Immunity: Vaccine …
According to the World Health Organization (WHO), ... Evvivax utilizes viral or plasmid DNA vectors for in vivo delivery of an expression cassette carrying the coding region of the target …See details»
EVVIVAX - Company Profile - Tracxn
EVVIVAX - Developer of nucleic-acid-based immunotherapies. EVVIVAX has 137 competitors.See details»
Linear DNA amplicons as a novel cancer vaccine strategy - PMC
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... Luigi Aurisicchio, Email: …See details»
Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
Nov 16, 2024 Takis and Evvivax have developed vaccines based on genetic technologies capable of inducing powerful immune responses. "Our technologies are based on genetic …See details»
Linear DNA amplicons as a novel cancer vaccine strategy
Jun 6, 2022 10 Evvivax, Via Castel Romano 100, 00128, Rome, Italy. [email protected]. 11 Neomatrix, Via Castel Romano 100, 00128, Rome, Italy. [email protected]. PMID: …See details»
COVID-eVax, an electroporated DNA vaccine candidate encoding …
T0002E0001 “Emergenza Coronavirus ed oltre” to Vitares no profit organization, and Fondazione Melanoma for providing support to develop the assays used in clinical trials. PHE activities …See details»
Applied DNA, EvviVax, and GVS Receive Regulatory Approval to
Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing, EvviVax, S.R.L., a spin-off of Takis Biotech with expertise in engineered veterinary cancer ...See details»
COVID-eVax, an electroporated DNA vaccine candidate encoding …
Jan 5, 2022 6 Evvivax Biotech, Via Castel Romano 100, 00128 Rome, Italy. 7 Neomatrix Biotech, Via Castel Romano 100, 00128 Rome, Italy. 8 Sackler School of Medicine, Tel Aviv …See details»
Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial
Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing that enables in vitro diagnostics, preclinical nucleic acid-based therapeutic drug candidates, …See details»
COVID-eVax, an electroporated DNA vaccine candidate ... - Europe …
Sep 20, 2021 Takis Biotech, Via Castel Romano 100, 00128 Rome, Italy; Evvivax Biotech, Via Castel Romano 100, 00128 Rome, Italy. 17 authors. 2. Takis Biotech, Via Castel Romano 100, …See details»
Applied DNA and EvviVax Announce Peer-Reviewed Publication of …
STONY BROOK, N.Y. and ROME, Italy---- Applied DNA Sciences, Inc., a leader in cell-free, enzymatic DNA production, and its program development partner, EvviVax, S.R.L., today …See details»
Tel-eVax: a genetic vaccine targeting telomerase for treatment of ...
Dec 11, 2018 5 BIOGEM Scarl, via Camporeale, 83031, Ariano Irpino, AV, Italy. [email protected]. 6 Evvivax s.r.l., via di Castel Romano 100, 00128, Rome, Italy. …See details»
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... 2 Evvivax s.r.l, Via di Castel Romano, …See details»
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
Feb 2, 2022 7 Evvivax, Rome, Italy. [email protected]. 8 Takis, Rome, Italy. [email protected]. 9 Neomatrix, Rome, Italy. [email protected]. …See details»
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding …
Mariano Maffei, Grazia Vitagliano, Shaila Sellathurai, Federica Bucci, Alessia Muzi and Valerio Chiarini are employees of the companies Evvivax and Takis. Mirco Compagnone is an …See details»
EVVIVAX - 103 Competitors and alternatives in Nov 2024 - Tracxn
Nov 3, 2024 EVVIVAX has 103 active competitors. Competitors include Embark Veterinary, AnimalBiome.See details»
Immunogenicity of COVID-eVax Delivered by Electroporation Is
Mar 16, 2023 4 Evvivax, 00128 Rome, Italy. PMID: 36992261 PMCID: PMC10054807 DOI: 10.3390/vaccines11030678 Abstract DNA integrity is a key issue in gene therapy and genetic …See details»